1. Introduction {#sec1}
===============

The dark-red liver is the body\'s largest single gland (1 to 1.5 kg). It is a metabolic middleman because it takes up and secretes more than 500 different kinds of molecules. The liver stores and releases glucose, keeping blood glucose levels relatively constant. The location of the liver reflects its middleman\'s role ([Figure 1](#fig1){ref-type="fig"}). The gland lies between the diaphragm above and the stomach and intestines below ([Figure 2](#fig2){ref-type="fig"}). Glucose and many other molecules enter the liver through the hepatic portal vein, and their products go directly through the inferior vena cava to the heart and lungs and then into the systemic circulation. The liver takes its dome-like shape from the diaphragm, which covers its superior surface, called diaphragmatic surface. The sagittal fossa divides the liver into two great lobes, right and left. The right lobe is larger and displays two smaller quadrate and caudate lobes on its visceral surface, defined by gallbladder and inferior vena cava, respectively \[[@B1]\]. The hepatic veins drain into the inferior vena cava arising from the posterior part of diaphragmatic surface of the liver. Visceral peritoneum binds the liver to the diaphragm and to the posterior wall of the abdomen.

Although there is an extensive bare area on the diaphragmatic surface of the liver where the peritoneum does not reach, the connective tissue attaches this area directly to the diaphragm. Most of the blood to the liver (70--80%) comes from the portal vein, and the smaller percentage is supplied by the hepatic artery ([Figure 3](#fig3){ref-type="fig"}). All the materials absorbed via the intestines reach the liver through the portal vein, except the complex lipids which are transported mainly by lymph vessels. The position of the liver in the circulatory system is optimal for gathering, transforming, and accumulating metabolites and for neutralizing and eliminating toxic substances. This elimination occurs in the form of bile, an exocrine secretion of the liver which is important in lipid digestion. The basic structural component of the liver is the liver cell or hepatocyte. In light microscope, structural units called classic liver lobules can be seen. The liver lobule is formed of a polygonal mass of tissue about 0.7 × 2 mm in size ([Figure 4](#fig4){ref-type="fig"}).

In certain animals (e.g., the pig), lobules are separated from each other by a layer of connective tissue. In humans, it is difficult to establish the exact limits between different lobules since they are in close contact in most of their extent ([Figure 5](#fig5){ref-type="fig"}). In some regions, the lobules are demarcated by connective tissue containing bile ducts, lymphatic vessels, nerves, and blood vessels. These regions, located at the corners of the lobules and occupied by portal triads, are called portal spaces. The human liver contains 3--6 portal triads per lobule, each with a venule (a branch of the portal vein); an arteriole (a branch of the hepatic artery); a duct (part of the bile duct system); and lymphatic vessels. The venule is usually the largest of these structures, containing blood from the superior and inferior mesenteric and splenic veins. An arteriole contains blood from the celiac trunk of the abdominal aorta.

The hepatocytes in the liver lobule are radially disposed and arranged like the bricks of a wall. These cellular plates are directed from the periphery of the lobule to its center and anastomose freely, forming a labyrinthine and sponge-like structure. The space between these plates contains capillaries, the liver sinusoids \[[@B2]\]. Portal and arterial blood mixes in the sinusoids and flows past hepatocytes, draining through a central vein from each lobule that leads ultimately to the hepatic veins. Bile from the lobules drains into the interlobular branches of the bile duct by way of bile canaliculi. The hepatic lobules act as endocrine and exocrine glands. In endocrine secretion, hepatocytes take up and secrete molecules into the sinusoids \[[@B1]\].

The liver has an extraordinary capacity for regeneration. Hence, the loss of hepatic tissue by surgical removal or from the action of toxic substances is restored. The liver performs its metabolic functions with the aid of various enzymes fixed inside liver cells. These liver cells line many capillaries (hepatic sinusoids) through which the total hepatic blood flow is manifolded, whereby exchange of substances between blood flow and cells is facilitated. The interplay of the unidirectional blood flow with local metabolism generates concentration gradients of blood-borne substances (such as oxygen) between the inlet and the outlet of the liver. The unidirectionality of that blood, that is, the blood flows form the portal triads to the central vein ([Figure 5](#fig5){ref-type="fig"}), has a major influence on the mathematical structure of the model, which appears to be capable of describing the formation of zones with a jump discontinuity at a certain distance along a capillary \[[@B3]\].

Several metabolic functions of the liver have been found to be organized in spatial zones arranged in relation to the direction of hepatic blood flow, in such a way that some enzymes act almost wholly upstream others \[[@B3]\]. Bass et al. \[[@B3]\] attributed such distributions of enzymes activities to distributions of cell types. For the simplest case of two enzymes, there are two corresponding cell types, each containing only one of the enzymes; separate metabolic zones occur when all cells of one type are located upstream all cells of the other type. Furthermore, it was reported in \[[@B3]\] that each cell type reproduces itself by division. The mathematical model was discussed in \[[@B3]\], but for convenience the main steps in its derivation are repeated in the next section. The mathematical model describing the formation of liver zones is a system of nonlinear integropartial differential equations. The objective of this paper is to apply Adomian\'s decomposition method to the system in order to find its stationary solutions (as the time tends to infinity) and the general solutions (at any position *x* and any time *t*) for arbitrary initial conditions.

2. Mathematical Modelling and Solutions {#sec2}
=======================================

2.1. Mathematical Formulation {#sec2.1}
-----------------------------

About 1100 milliliters of blood flows from the portal vein into the liver sinusoids ([Figure 6](#fig6){ref-type="fig"}) each minute, and approximately an additional 350 milliliters flows into the sinusoids from the hepatic artery, the total averaging is about 1450 mL/min. This amounts to about 29% of the resting cardiac output. As the many capillaries comprising the liver are similar and act essentially in parallel, Bass et al. \[[@B3]\] modelled a representative capillary lined with cells of two kinds. It was suggested to put the *x*-axis along the blood flow, with inlet at *x* = 0 and outlet at *x* = *L* \[[@B3]\]. The density of cells of the first kind is defined by *ρ* ~1~(*x*, *t*) as a continuous representation of the number of cells of the first kind per unit length of capillary at time *t* at the position *x*. The density *ρ* ~2~(*x*, *t*) of cells of the second kind is defined analogously. The total cell density *ρ* ~1~ + *ρ* ~2~ cannot exceed some fixed maximum density *σ* of cell sites, as division of the cell is limited by the familiar phenomenon of contact inhibition. The local rate of change ∂*ρ* ~1~/∂*t* of the density of cells of the first kind is assumed to consist of a growth rate term proportional to *ρ* ~1~ (self-generation) and to the density of sites available, *σ* − *ρ* ~1~ − *ρ* ~2~, and of a death rate term proportional to *ρ* ~1~, with a coefficient *β* ~1~(*c*) \> 0 dependent on the local concentration *c* of a controlling blood-borne substance. In what follows, for definiteness, oxygen is taken as that substance. Then $$\begin{matrix}
{\frac{\partial\rho_{1}}{\partial t} = K_{1}\rho_{1}\left( {\sigma - \rho_{1} - \rho_{2}} \right) - \beta_{1}\left( c \right)\rho_{1},} \\
\end{matrix}$$ with a constant coefficient *K* ~1~ \> 0. A similar equation for *ρ* ~2~ is obtained from ([1](#EEq2.1){ref-type="disp-formula"}) by interchanging the suffices 1, 2. So $$\begin{matrix}
{\frac{\partial\rho_{2}}{\partial t} = K_{2}\rho_{2}\left( {\sigma - \rho_{1} - \rho_{2}} \right) - \beta_{2}\left( c \right)\rho_{2}.} \\
\end{matrix}$$ Let *f* be the steady rate of blood flow through the capillary. If oxygen is transported in the *x*-direction predominantly by convection with the blood and used up by the two cell types at the rates *k* ~1~ *ρ* ~1~ and *k* ~2~ *ρ* ~2~ (with positive constants *k* ~1~, *k* ~2~), then changes in *c* caused by changes in *ρ* ~1~ and *ρ* ~2~ are quasisteady. Therefore, *c* satisfies $$\begin{matrix}
{f\frac{\partial c}{\partial x} = - k_{1}\rho_{1} - k_{2}\rho_{2}.} \\
\end{matrix}$$ If ([3](#EEq2.3){ref-type="disp-formula"}) is integrated, then $$\begin{matrix}
{c\left( {x,t} \right) = c_{0} - \frac{1}{f}\int_{0}^{x}\left\lbrack {k_{1}\rho_{1}\left( {\xi,t} \right) + k_{2}\rho_{2}\left( {\xi,t} \right)} \right\rbrack d\xi,} \\
\end{matrix}$$ where *c* ~0~ is the steady oxygen concentration in the blood entering the liver. It is assumed that as oxygen concentration falls, the death rate of cells increases (*dβ* ~1~(*c*)/*dc* ≤ 0, *dβ* ~2~(*c*)/*dc* ≤ 0), though not necessarily equally for both cell types. It is assumed that *β* ~1~(*c*) has the following form (similarly for *β* ~2~(*c*)): $$\begin{matrix}
{\beta_{1}\left( c \right) = \mu_{1} + \nu_{1}\left( {c_{0} - c} \right),} \\
\end{matrix}$$ where $$\begin{matrix}
{\mu_{1} = \beta_{1}\left( c_{0} \right) \geq 0,\quad\quad\nu_{1} = - \left. \frac{d\beta_{1}}{dc} \right|_{c_{0}} \geq 0.} \\
\end{matrix}$$ Introducing ([4](#EEq2.4){ref-type="disp-formula"}) and ([5](#EEq2.5){ref-type="disp-formula"}) into ([1](#EEq2.1){ref-type="disp-formula"}) and ([2](#EEq2.2){ref-type="disp-formula"}), we arrive at the pair of equations $$\begin{matrix}
{\frac{\partial\rho_{1}}{\partial t} = \rho_{1}\left\lbrack {K_{1}\left( {\sigma - \rho_{1} - \rho_{2}} \right) - \mu_{1} - \frac{\nu_{1}}{f}\int_{0}^{x}\left( {k_{1}\rho_{1} + k_{2}\rho_{2}} \right)d\xi} \right\rbrack,} \\
{\frac{\partial\rho_{2}}{\partial t} = \rho_{2}\left\lbrack {K_{2}\left( {\sigma - \rho_{1} - \rho_{2}} \right) - \mu_{2} - \frac{\nu_{2}}{f}\int_{0}^{x}\left( {k_{1}\rho_{1} + k_{2}\rho_{2}} \right)d\xi} \right\rbrack.} \\
\end{matrix}$$ If *K* ~1~ *σ* ≤ *μ* ~1~, then *ρ* ~1~(*x*, *t*) → 0 as *t* → *∞* for all *x*, and similarly for *ρ* ~2~. Therefore, it is assumed that *K* ~1~ *σ* \> *μ* ~1~ and *K* ~2~ *σ* \> *μ* ~2~. For similar reasons, it is assumed that at least one of *ν* ~1~ and *ν* ~2~ is positive (say *ν* ~1~). It is noted at once that unless the first cell type is inevitably to die out, its greatest possible specific growth rate *K* ~1~ *σ* must exceed its least possible specific death rate *μ* ~1~. Similar remarks apply for the second cell type, and accordingly it is assumed in \[[@B3]\] that $$\begin{matrix}
{K_{1}\sigma > \mu_{1},\quad\quad K_{2}\sigma > \mu_{2}.} \\
\end{matrix}$$ To obtain some preliminary heuristic ideas about the formation of zones in their model, Bass et al. \[[@B3]\] supposed that ([7](#EEq2.7){ref-type="disp-formula"}) admits solutions which at all finite times are everywhere positive and satisfy (*ρ* ~1~ + *ρ* ~2~) \< *σ*. For such solutions, ([7](#EEq2.7){ref-type="disp-formula"}) can be written in the form $$\begin{matrix}
{\frac{\partial}{\partial t}\ln\rho_{1} = K_{1}\left( {\sigma - \rho_{1} - \rho_{2}} \right) - \mu_{1} - \frac{\nu_{1}}{f}\int_{0}^{x}\left( {k_{1}\rho_{1} + k_{2}\rho_{2}} \right)d\xi,} \\
{\frac{\partial}{\partial t}\ln\rho_{2} = K_{2}\left( {\sigma - \rho_{1} - \rho_{2}} \right) - \mu_{2} - \frac{\nu_{2}}{f}\int_{0}^{x}\left( {k_{1}\rho_{1} + k_{2}\rho_{2}} \right)d\xi.} \\
\end{matrix}$$ Multiplying the first equation in ([9](#EEq2.9){ref-type="disp-formula"}) by *K* ~2~ and the second by *K* ~1~, we have $$\begin{matrix}
{\frac{\partial}{\partial t}\ln\rho_{1}^{K_{2}} = K_{1}K_{2}\left( {\sigma - \rho_{1} - \rho_{2}} \right) - \mu_{1}K_{1}} \\
{- \frac{\nu_{1}K_{1}}{f}\int_{0}^{x}\left( {k_{1}\rho_{1} + k_{2}\rho_{2}} \right)d\xi,} \\
{\frac{\partial}{\partial t}\ln\rho_{2}^{K_{1}} = K_{1}K_{2}\left( {\sigma - \rho_{1} - \rho_{2}} \right) - \mu_{2}K_{2}} \\
{- \frac{\nu_{2}K_{2}}{f}\int_{0}^{x}\left( {k_{1}\rho_{1} + k_{2}\rho_{2}} \right)d\xi.} \\
\end{matrix}$$

2.2. The Stationary Solutions {#sec2.2}
-----------------------------

For such solutions, we can combine ([10](#EEq2.10){ref-type="disp-formula"}) in the form $$\begin{matrix}
{\frac{\partial}{\partial t}\left\lbrack {\ln\left( \frac{\rho_{1}^{K_{2}}}{\rho_{2}^{K_{1}}} \right)} \right\rbrack = A - \frac{B}{f}\int_{0}^{x}\left( {k_{1}\rho_{1} + k_{2}\rho_{2}} \right)d\xi,} \\
\end{matrix}$$ where $$\begin{matrix}
{A = \mu_{2}K_{1} - \mu_{1}K_{2},\quad\quad B = \nu_{1}K_{2} - \nu_{2}K_{1}.} \\
\end{matrix}$$ Suppose that *μ* ~2~ *K* ~1~ \> *μ* ~1~ *K* ~2~, *ν* ~1~ *K* ~2~ \> *ν* ~2~ *K* ~1~, or $$\begin{matrix}
{\frac{\mu_{2}}{K_{2}} > \frac{\mu_{1}}{K_{1}},\quad\quad\frac{\nu_{2}}{K_{2}} < \frac{\nu_{1}}{K_{1}},} \\
\end{matrix}$$ so that the constants *A* and *B* are positive. Since the integral in ([11](#EEq2.11){ref-type="disp-formula"}) is bounded above by (*k* ~1~ + *k* ~2~)*xσ*, the right-hand side of ([11](#EEq2.11){ref-type="disp-formula"}) is positive at all times for sufficiently small *x*, where $$\begin{matrix}
{x < \frac{Af}{\left( {k_{1} + k_{2}} \right)\sigma B}.} \\
\end{matrix}$$ Volterra\'s argument \[[@B3]\] then applies: as *t* → *∞*, *ρ* ~1~ ^*K*~2~^/*ρ* ~2~ ^*K*~1~^ → *∞*, and with *ρ* ~1~ bounded above by *σ*, *ρ* ~2~ must tends to zero. It is then plausible that for these values of *x* in ([14](#EEq2.14){ref-type="disp-formula"}), *ρ* ~1~ will approach a stationary form determined from the first equations of ([7](#EEq2.7){ref-type="disp-formula"}) with *ρ* ~2~ = 0, namely \[[@B3], [@B4]\], $$\begin{matrix}
{K_{1}\left( {\sigma - \rho_{1}} \right) - \mu_{1} - \frac{\nu_{1}}{f}\int_{0}^{x}k_{1}\rho_{1}d\xi = 0.} \\
\end{matrix}$$ In order to solve this equation by Adomian\'s decomposition method \[[@B5]--[@B13]\], we put the equation in the form $$\begin{matrix}
{\rho_{1} = \frac{c_{1}}{K_{1}} - \left( \frac{\nu_{1}k_{1}}{fK_{1}} \right)\int_{0}^{x}\rho_{1}d\xi,} \\
\end{matrix}$$ where $$\begin{matrix}
{c_{i} = K_{i}\sigma - \mu_{1},\quad i = 1,2.} \\
\end{matrix}$$ According to Adomian\'s method, *ρ* ~1~ is assumed as $$\begin{matrix}
{\rho_{1} = \sum\limits_{n = 0}^{\infty}\rho_{1n}.} \\
\end{matrix}$$ Substituting ([18](#EEq2.18){ref-type="disp-formula"}) into ([16](#EEq2.16){ref-type="disp-formula"}), we obtain $$\begin{matrix}
{\sum\limits_{n = 0}^{\infty}\rho_{1n} = \frac{c_{1}}{K_{1}} - \left( \frac{\nu_{1}k_{1}}{fK_{1}} \right)\sum\limits_{n = 0}^{\infty}\int_{0}^{x}\rho_{1n}d\xi.} \\
\end{matrix}$$ Let $$\begin{matrix}
{\rho_{10} = \frac{c_{1}}{K_{1}}.} \\
\end{matrix}$$ Then the solution can be elegantly computed by using the recurrence relation $$\begin{matrix}
{\rho_{1({n + 1}){\,\,}} = - \frac{\nu_{1}k_{1}}{fK_{1}}\int_{0}^{x}\rho_{1n}d\xi,\quad n \geq 0.} \\
\end{matrix}$$ This gives $$\begin{matrix}
{\rho_{11}\left( x \right) = \left( \frac{- \nu_{1}k_{1}}{fK_{1}} \right)\frac{c_{1}}{K_{1}}x,} \\
{\rho_{12}\left( x \right) = \left( {- \frac{\nu_{1}k_{1}}{fK_{1}}} \right)^{2}\frac{c_{1}}{K_{1}}\frac{x^{2}}{2!},} \\
{\rho_{13}\left( x \right) = \left( {- \frac{\nu_{1}k_{1}}{fK_{1}}} \right)^{3}\frac{c_{1}}{K_{1}}\frac{x^{3}}{3!},} \\
 \vdots \\
{\rho_{1n}\left( x \right) = \left( {- \frac{\nu_{1}k_{1}}{fK_{1}}} \right)^{n}\frac{c_{1}}{K_{1}}\frac{x^{n}}{n!},\quad n \geq 0.} \\
\end{matrix}$$ According to ([18](#EEq2.18){ref-type="disp-formula"}), we obtain *ρ* ~1~ in the form $$\begin{matrix}
{\rho_{1}\left( x \right) = \rho_{1}^{\ast}\left( x \right) = \frac{c_{1}}{K_{1}}\exp\left\lbrack {- \frac{\nu_{1}k_{1}}{fK_{1}}x} \right\rbrack.} \\
\end{matrix}$$ Set *ρ* ~2~ equal to zero and *ρ* ~1~ equal to *ρ* ~1~\*, then ([11](#EEq2.11){ref-type="disp-formula"}) becomes $$\begin{matrix}
{\frac{\partial}{\partial t}\left\lbrack {{\ln}\left( \frac{\rho_{1}^{K_{2}}}{\rho_{2}^{K_{1}}} \right)} \right\rbrack = A - \frac{Bc_{1}}{\nu_{1}}\left\lbrack {1 - \exp\left( {- \frac{\nu_{1}k_{1}}{fK_{1}}x} \right)} \right\rbrack.} \\
\end{matrix}$$ We note that the right-hand side of ([24](#EEq2.24){ref-type="disp-formula"}) decreases with increasing *x* and reaches zero at a value *x* = *x*\* determined by $$\begin{matrix}
{\exp\left( \frac{\nu_{1}k_{1}x^{\ast}}{fK_{1}} \right) = \frac{Bc_{1}}{K_{1}\left( {\nu_{1}c_{2} - \nu_{2}c_{1}} \right)}.} \\
\end{matrix}$$ Provided that $$\begin{matrix}
{\nu_{1}c_{2} > \nu_{2}c_{1}.} \\
\end{matrix}$$ The point *x* = *x*\* determined by ([25](#EEq2.25){ref-type="disp-formula"}) lies in the interval (0, *L*) of interest provided that $$\begin{matrix}
{\exp\left( \frac{\nu_{1}k_{1}L}{fK_{1}} \right) > \frac{Bc_{1}}{K_{1}\left( {\nu_{1}c_{2} - \nu_{2}c_{1}} \right)}.} \\
\end{matrix}$$ Under these conditions, it is then reasonable to suppose that, for *x* \> *x*\*, the right-hand side of ([11](#EEq2.11){ref-type="disp-formula"}) will in fact be negative for sufficiently large values of *t* \[[@B3]\]. Volterra\'s argument then indicates that we can expect to find *ρ* ~1~ → 0 as *t* → *∞* for *x* \> *x*\*. Furthermore, we may also expect that, for *x* \> *x*\*, *ρ* ~2~ will approach a stationary form determined from the second equation of ([7](#EEq2.7){ref-type="disp-formula"}) by $$\begin{matrix}
{K_{2}\left( {\sigma - \rho_{2}} \right) - \mu_{2} - \frac{\nu_{2}}{f}\left\lbrack {\int_{0}^{x^{\ast}}k_{1}\rho_{1}^{\ast}d\xi + \int_{x^{\ast}}^{x}k_{2}\rho_{2}d\xi} \right\rbrack = 0.} \\
\end{matrix}$$ This equation can be solved by Adomian\'s method; we rewrite the equation in the form $$\begin{matrix}
{\rho_{2} + \frac{\nu_{2}k_{2}}{fK_{2}}\int_{x^{\ast}}^{x}\rho_{2}d\xi = D,} \\
\end{matrix}$$ where $$\begin{matrix}
{D = \frac{\nu_{1}c_{2} - \nu_{2}c_{1}}{B}.} \\
\end{matrix}$$ We assume that $$\begin{matrix}
{\rho_{2} = \sum\limits_{n = 0}^{\infty}\rho_{2n}.} \\
\end{matrix}$$ Let *ρ* ~20~ = *D*, then the solution can be computed by using the recurrence relation $$\begin{matrix}
{\rho_{2({n + 1})} = - \frac{\nu_{2}k_{2}}{fK_{2}}\int_{x^{\ast}}^{x}\rho_{2n}d\xi,\quad n \geq 0.} \\
\end{matrix}$$ This gives $$\begin{matrix}
{\rho_{21} = - \frac{- \nu_{2}k_{2}}{fK_{2}}D\left( {x - x^{\ast}} \right),} \\
{\rho_{22} = \left( {- \frac{\nu_{2}k_{2}}{fK_{2}}} \right)^{2}D\frac{\left( {x - x^{\ast}} \right)^{2}}{2!},} \\
 \vdots \\
{\rho_{2n} = \left( {- \frac{\nu_{2}k_{2}}{fK_{2}}} \right)^{n}D\frac{\left( {x - x^{\ast}} \right)^{n}}{n!},\quad n \geq 0.} \\
\end{matrix}$$ Therefore $$\begin{matrix}
{\rho_{2} = \rho_{2}^{\ast}\left( x \right) = D\exp\left\lbrack {- \frac{\nu_{2}k_{2}}{fK_{2}}\left( {x - x^{\ast}} \right)} \right\rbrack,\quad x > x^{\ast}.} \\
\end{matrix}$$ So, as *t* → *∞*, the formation of liver zones can be described as follows: $$\begin{matrix}
{\rho_{1} = \rho_{1}^{\ast}\left( x \right),\quad\rho_{2} = 0,\quad 0 \leq x < x^{\ast},} \\
{\rho_{1} = 0,\quad\rho_{2} = \rho_{2}^{\ast}\left( x \right),\quad x^{\ast} < x \leq L.} \\
\end{matrix}$$

3. Analytical Solutions {#sec3}
=======================

In applied mathematics, Adomian\'s decomposition method is an effective procedure to obtain analytic and approximate solutions for different types of equations. This method is used here to obtain a general solution for the system ([7](#EEq2.7){ref-type="disp-formula"}). Following Bass et al. \[[@B3]\], we define new variables $$\begin{matrix}
{t^{\prime} = c_{1}t,\quad\quad x^{\prime} = \frac{\nu_{1}k_{1}}{fK_{1}}x,\quad\quad v_{i}\left( {t^{\prime},x^{\prime}} \right) = \frac{K_{1}}{c_{1}}\rho_{i}\left( {t,x} \right)} \\
\end{matrix}$$ and new parameters $$\begin{matrix}
{\theta = \frac{k_{2}}{k_{1}},\quad\quad\gamma = \frac{K_{2}}{K_{1}},\quad\quad\lambda = \frac{K_{1}c_{2}}{K_{2}c_{1}},\quad\quad\eta = \frac{\nu_{2}K_{1}}{\nu_{1}K_{2}}.} \\
\end{matrix}$$ Then ([7](#EEq2.7){ref-type="disp-formula"}) becomes, on dropping at once the primes from the new independent variables, $$\begin{matrix}
{\frac{\partial v_{1}}{\partial t} = v_{1}\left\lbrack {1 - v_{1} - v_{2} - \int_{0}^{x}\left\lbrack {v_{1}\left( {t,\xi} \right) + \theta v_{2}\left( {t,\xi} \right)} \right\rbrack d\xi} \right\rbrack,} \\
{\frac{\partial v_{2}}{\partial t} = \gamma v_{2}\left\lbrack {\lambda - v_{1} - v_{2} - \eta\int_{0}^{x}\left\lbrack {v_{1}\left( {t,\xi} \right) + \theta v_{2}\left( {t,\xi} \right)} \right\rbrack d\xi} \right\rbrack,} \\
\end{matrix}$$ with constant parameters $$\begin{matrix}
{\theta > 0,\quad\quad\gamma > 0,\quad\quad\lambda > 0,\quad\quad\eta \geq 0.} \\
\end{matrix}$$ The spatial interval of interest is now \[0, Λ\], where Λ = (*ν* ~1~ *k* ~1~/*fK* ~1~)*L*, and then we have \[[@B3]\] $$\begin{matrix}
{\eta < \lambda < 1,\quad\quad\ln\left( \frac{1 - \eta}{\lambda - \eta} \right) < \Lambda.} \\
\end{matrix}$$ The stationary solutions become $$\begin{matrix}
{v_{1} = e^{- x},\quad v_{2} = 0,\quad 0 \leq x < x^{\ast},} \\
{v_{1} = 0,\quad v_{2} = \left( \frac{\lambda - \eta}{1 - \eta} \right)e^{- \eta\theta({x - x^{\ast}})},\quad x^{\ast} < x \leq \Lambda,} \\
\end{matrix}$$ where now $$\begin{matrix}
{x^{\ast} = \ln\left( \frac{1 - \eta}{\lambda - \eta} \right).} \\
\end{matrix}$$ For searching analytical solutions, we firstly rewrite the system we want to solve as two separate integro-partial differential equations: $$\begin{matrix}
{\frac{\partial v_{1}}{\partial t} = v_{1}\left\lbrack {1 - v_{1} - v_{2} - \int_{0}^{x}\left( {v_{1} + \theta v_{2}} \right)d\xi} \right\rbrack,} \\
\end{matrix}$$ $$\begin{matrix}
{\frac{\partial v_{2}}{\partial t} = \gamma v_{2}\left\lbrack {\lambda - v_{1} - v_{2} - \eta\int_{0}^{x}\left( {v_{1} + \theta v_{2}} \right)d\xi} \right\rbrack.} \\
\end{matrix}$$ According to the decomposition method, we assume that $$\begin{matrix}
{v_{1} = \sum\limits_{n = 0}^{\infty}v_{1n},\quad\quad v_{2} = \sum\limits_{n = 0}^{\infty}v_{2n}.} \\
\end{matrix}$$ Equation ([43](#EEq3.8){ref-type="disp-formula"}) can be put in the following operator form: $$\begin{matrix}
{L_{t}v_{1} = v_{1} - v_{1}^{2} - v_{1}v_{2} - v_{1}\int_{0}^{x}\left( {v_{1}\left( {t,\xi} \right) + \theta v_{2}\left( {t,\xi} \right)} \right)d\xi,} \\
{\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad L_{t} = \frac{\partial}{\partial t}.} \\
\end{matrix}$$ Applying the inverse operator *L* ~*t*~ ^−1^\[·\] = ∫~0~ ^*t*^\[·\]*dt*, on both sides of this equation, yields $$\begin{matrix}
{v_{1} - v_{1}\left( {x,0} \right) = L_{t}^{- 1}v_{1} - L_{t}^{- 1}v_{1}^{2} - L_{t}^{- 1}v_{1}v_{2}} \\
{- L_{t}^{- 1}v_{1}\int_{0}^{x}\left( {v_{1} + \theta v_{2}} \right)d\xi.} \\
\end{matrix}$$ Substituting ([45](#EEq3.10){ref-type="disp-formula"}) into ([47](#EEq3.12){ref-type="disp-formula"}), we obtain $$\begin{matrix}
{v_{1} = v_{1}\left( {x,0} \right) + L_{t}^{- 1}\sum\limits_{n = 0}^{\infty}v_{1n}} \\
{- L_{t}^{- 1}\sum\limits_{n = 0}^{\infty}\sum\limits_{k = 0}^{n}v_{1k}v_{1({n - k})} - L_{t}^{- 1}\sum\limits_{n = 0}^{\infty}\sum\limits_{k = 0}^{n}v_{1k}v_{2({n - k})}} \\
{- L_{t}^{- 1}\sum\limits_{n = 0}^{\infty}v_{1n}\int_{0}^{x}\sum\limits_{n = 0}^{\infty}\left( {v_{1n} + \theta v_{2n}} \right)d\xi.} \\
\end{matrix}$$ Now, the solution *v* ~1~ can be evaluated through the recursive scheme: $$\begin{matrix}
{v_{10}\left( x,t \right) = v_{1}\left( x,0 \right),} \\
{v_{1({n + 1})}\left( {x,t} \right) = L_{t}^{- 1}v_{1n} - L_{t}^{- 1}\left( {\sum\limits_{k = 0}^{n}v_{1k}v_{1({n - k})}} \right)} \\
{- L_{t}^{- 1}\left( {\sum\limits_{k = 0}^{n}v_{1k}v_{2({n - k})}} \right) - L_{t}^{- 1}\sum\limits_{k = 0}^{n}v_{1k}} \\
{\times \int_{0}^{x}\left( {v_{1({n - k})} + \theta v_{2({n - k})}} \right)d\xi,\quad n \geq 0.} \\
\end{matrix}$$ By similar analysis, we can get the solution *v* ~2~ by the recursive scheme: $$\begin{matrix}
{v_{20}\left( x,t \right) = v_{2}\left( x,0 \right),} \\
{v_{2({n + 1})}\left( {x,t} \right) = \gamma\lambda L_{t}^{- 1}v_{2n} - \gamma L_{t}^{- 1}\left( {\sum\limits_{k = 0}^{n}v_{1k}v_{2({n - k})}} \right)} \\
{- \gamma L_{t}^{- 1}\left( {\sum\limits_{k = 0}^{n}v_{2k}v_{2({n - k})}} \right) - \gamma\lambda L_{t}^{- 1}\sum\limits_{k = 0}^{n}v_{2k}} \\
{\times \int_{0}^{x}\left( {v_{1({n - k})} + \theta v_{2({n - k})}} \right)d\xi,\quad n \geq 0.} \\
\end{matrix}$$ For simplicity, we assume that the two types of the liver cells have the same distribution along the hepatic capillary at *t* = 0; that is, $$\begin{matrix}
{v_{1}\left( {x,0} \right) = v_{2}\left( {x,0} \right);} \\
{\text{that}{\,\,}\text{is},v_{10}\left( x \right) = v_{20}\left( x \right) = v_{0}\left( x \right)\left( \text{say} \right).} \\
\end{matrix}$$ By this, we can get the first few terms of Adomian\'s series from the recurrence relations ([49](#EEq3.14){ref-type="disp-formula"}) and ([50](#EEq3.15){ref-type="disp-formula"}) as follows: $$\begin{matrix}
{v_{11}\left( {x,t} \right) = v_{0}\left\lbrack {1 - 2v_{0} - \left( {1 + \theta} \right)I_{1}\left( x \right)} \right\rbrack t,} \\
{v_{21}\left( {x,t} \right) = \gamma v_{0}\left( {\lambda - 2v_{0} - \eta\left( {1 + \theta} \right)I_{1}\left( x \right)} \right)t,} \\
{v_{12} = v_{0}\left\{ {\left\lbrack {1 - 3v_{0} - \left( {1 + \theta} \right)I_{1}\left( x \right)} \right\rbrack\left\lbrack {1 - 2v_{0} - \left( {1 + \theta} \right)I_{1}\left( x \right)} \right\rbrack} \right.} \\
{\quad   - \gamma v_{0}\left\lbrack {\lambda - 2v_{0} - \eta\left( {1 + \theta} \right)I_{1}\left( x \right)} \right\rbrack - \left( {1 + \gamma\theta\lambda} \right)I_{1}\left( x \right)} \\
{\left. {\quad   + 2\left( {1 + \gamma\theta} \right)I_{2}\left( x \right)\left( {1 + \gamma\eta\theta} \right)\left( {1 + \theta} \right)I_{3}\left( x \right)} \right\}\frac{t^{2}}{2!},} \\
{v_{22} = \left\{ \left\lbrack {\gamma\lambda - 3\gamma v_{0} - \gamma\eta\left( {1 + \theta} \right)I_{1}\left( x \right)} \right\rbrack \right.} \\
{  \times \left\lbrack {\gamma\lambda v_{0} - 2\gamma v_{0}^{2} - \gamma\eta\left( {1 + \theta} \right)v_{0}I_{1}\left( x \right)} \right\rbrack} \\
{  - \left\lbrack {\gamma v_{0}^{2} - 2\gamma v_{0}^{3} - \gamma\left( {1 + \theta} \right)v_{0}^{2}I_{1}\left( x \right)} \right\rbrack} \\
{  - \gamma\eta\left( {1 + \gamma\theta\lambda} \right)v_{0}I_{1}\left( x \right) + 2\gamma\eta\left( {1 + \gamma\theta} \right)v_{0}I_{2}\left( x \right)} \\
{\left. {  + \gamma\eta\left( {1 + \theta} \right)\left( {1 + \gamma\eta\theta} \right)v_{0}I_{3}\left( x \right)} \right\}\frac{t^{2}}{2!},} \\
\end{matrix}$$ where $$\begin{matrix}
{I_{1}\left( x \right) = \int_{0}^{x}v_{0}d\xi,\quad\quad I_{2}\left( x \right) = \int_{0}^{x}v_{0}^{2}d\xi,} \\
{I_{3}\left( x \right) = \int_{0}^{x}I_{1}\left( \xi \right)v_{0}d\xi.} \\
\end{matrix}$$

4. Remarks {#sec4}
==========

Here, we indicate that at particular values of the parameters *γ*, *λ*, and *η*, the solutions *v* ~1~ and *v* ~2~ are equivalent. In order to do this, we prefer to put the solutions *v* ~1~ and *v* ~2~ in the form $$\begin{matrix}
{v_{1}\left( {x,t} \right) = \alpha_{0}\left( x \right) + \alpha_{1}\left( x \right)t + \alpha_{2}\left( x \right)t^{2} + \cdots,} \\
{v_{2}\left( {x,t} \right) = \beta_{0}\left( x \right) + \beta_{1}\left( x \right)t + \beta_{2}\left( x \right)t^{2} + \cdots,} \\
\end{matrix}$$ where $$\begin{matrix}
{\alpha_{0}\left( x \right) = \beta_{0}\left( x \right) = v_{0}\left( x \right),} \\
{\alpha_{1}\left( x \right) = v_{0}\left\lbrack {1 - 2v_{0} - \left( {1 + \theta} \right)I_{1}\left( x \right)} \right\rbrack,} \\
{\alpha_{2}\left( x \right) = \frac{1}{2!}v_{0}\left\lbrack {1 - 3v_{0} - \left( {1 + \theta} \right)I_{1}\left( x \right)} \right\rbrack} \\
{\times \left\lbrack {1 - 2v_{0} - \left( {1 + \theta} \right)I_{1}\left( x \right)} \right\rbrack} \\
{- \gamma v_{0}\left\lbrack {\lambda - 2v_{0} - \eta\left( {1 + \theta} \right)I_{1}\left( x \right)} \right\rbrack - \left( {1 + \gamma\theta\lambda} \right)I_{1}\left( x \right)} \\
{+ 2\left( {1 + \gamma\theta} \right)I_{2}\left( x \right) + \left( {1 + \gamma\eta\theta} \right)\left( {1 + \theta} \right)I_{3}\left( x \right),} \\
{\beta_{1}\left( x \right) = \gamma v_{0}\left\lbrack {\lambda - 2v_{0} - \left( {1 + \theta} \right)I_{1}\left( x \right)} \right\rbrack,} \\
{\beta_{2}\left( x \right) = \frac{1}{2!}\left\{ \left\lbrack {\gamma\lambda - 3\gamma v_{0} - \gamma\eta\left( {1 + \theta} \right)I_{1}\left( x \right)} \right\rbrack \right.} \\
{\quad   \times \left\lbrack {\gamma\lambda v_{0} - 2\gamma v_{0}^{2} - \gamma\eta\left( {1 + \theta} \right)v_{0}I_{1}\left( x \right)} \right\rbrack} \\
{\quad   - \left\lbrack {\gamma v_{0}^{2} - 2\gamma v_{0}^{3} - \gamma\left( {1 + \theta} \right)v_{0}^{2}I_{1}\left( x \right)} \right\rbrack} \\
{\quad   - \eta\left( {1 + \gamma\theta\lambda} \right)v_{0}I_{1}\left( x \right) + 2\gamma\eta\left( {1 + \gamma\theta} \right)v_{0}I_{2}\left( x \right)} \\
{\left. {\quad   + \gamma\eta\left( {1 + \theta} \right)\left( {1 + \gamma\eta\theta} \right)v_{0}I_{3}\left( x \right)} \right\}.} \\
\end{matrix}$$ Firstly, substituting *γ* = *λ* = *η* = 1 into the original equations ([38](#EEq3.3){ref-type="disp-formula"}), we obtain $$\begin{matrix}
{\frac{1}{v_{1}}\frac{\partial v_{1}}{\partial t} = 1 - v_{1} - v_{2} - \int_{0}^{x}\left( {v_{1} + \theta v_{2}} \right)d\xi,} \\
{\frac{1}{v_{2}}\frac{\partial v_{2}}{\partial t} = 1 - v_{1} - v_{2} - \int_{0}^{x}\left( {v_{1} + \theta v_{2}} \right)d\xi.} \\
\end{matrix}$$ We can combine these equations in the form $$\begin{matrix}
{\frac{\partial}{\partial t}\left\lbrack {\ln v_{1}\left( {x,t} \right)} \right\rbrack = \frac{\partial}{\partial t}\left\lbrack {\ln v_{2}\left( {x,t} \right)} \right\rbrack.} \\
\end{matrix}$$ By integrating both sides with respect to *t* from 0 to *t*, we get $$\begin{matrix}
{\ln\left\lbrack \frac{v_{1}\left( {x,t} \right)}{v_{0}\left( x \right)} \right\rbrack = \ln\left\lbrack \frac{v_{2}\left( {x,t} \right)}{v_{0}\left( x \right)} \right\rbrack,} \\
\end{matrix}$$ where we used the relation *v* ~1~(*x*, 0) = *v* ~2~(*x*, 0) = *v* ~0~(*x*). Thus, *v* ~1~(*x*, *t*) = *v* ~2~(*x*, *t*). Now, substituting *γ* = *λ* = *η* = 1 into ([55](#EEq3.20){ref-type="disp-formula"}), we can easily observe that $$\begin{matrix}
{\alpha_{0}\left( x \right) = \beta_{0}\left( x \right),\quad\quad\alpha_{1}\left( x \right) = \beta_{1}\left( x \right),\quad\quad\alpha_{2}\left( x \right) = \beta_{2}\left( x \right),} \\
\end{matrix}$$ which leads also to *v* ~1~(*x*, *t*) = *v* ~2~(*x*, *t*).

5. Conclusion {#sec5}
=============

In this paper, the Adomian decomposition method has been applied successfully to a system of nonlinear integro-partial differential equations describing the formation of liver zones. As time tends to infinity, the stationary solutions are obtained in exact forms by using Adomian\'s method, where full agreement with those obtained in the literature has been achieved. Also, at any time of the liver regeneration process, the analytical solutions are obtained explicitly in series form. Finally, the current solutions may shed some light on the mathematical aspects of the formation of liver zones and also on describing the distribution of the two types of the liver cells.

The author wishes to express his thanks to Professor Mostafa El-Shahed for his kind help and very valuable suggestions.
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